Ann Arbor Stage II Non-Hodgkin Lymphoma
1 clinical trials · Condition
◉ Watch Ann Arbor Stage II Non-Hodgkin Lymphoma
| Record | Firm | Date |
|---|---|---|
| Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma (NCT00972478) | National Cancer Institute (NCI) | 2010-11-15 |
Track Ann Arbor Stage II Non-Hodgkin Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.